ESPE Abstracts (2019) 92 P1-211

Fetal, Neonatal Endocrinology and Metabolism (to include Hypoglycaemia) (1)

Characteristics of Children with Kabuki Syndrome and Hyperinsulinemic Hypoglycemia

Henrike Hoermann1, Omar El-Rifai2, Martin Schebek3, Klaus Brusgaard4,5, Nadine Bachmann6, Carsten Bergmann6, Ertan Mayatepek1, Henrik Christesen2,7, Thomas Meissner1, Sebastian Kummer1


1Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Duesseldorf, Germany. 2Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark. 3Department of Pediatric Diabetes, Children's Hospital Kassel, Kassel, Germany. 4Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. 5Institute of Clinical Research, University of Southern Denm, Odense, Denmark. 6Bioscientia Center for Human Genetics, Ingelheim, Germany. 7Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Background: Kabuki syndrome (KS) is a rare multiple congenital malformation and intellectual disability syndrome. KS is caused by pathogenic variants in the genes KMT2D or KDM6A. In 0.3-4% of patients, KS is reported to be associated with hyperinsulinemic hypoglycemia. The objective of this study was to characterize the clinical, biochemical and molecular data of children with KS and hyperinsulinemic hypoglycemia.

Methods: Clinical, biochemical and molecular data from 5 children with KS and hyperinsulinemic hypoglycemia from three centres were retrospectively analysed.

Results: 5 female patients were identified with 5 different pathogenic variants in KDM6A (n = 3) and KMT2D (n = 2). All of them presented hyperinsulinemic hypoglycemia at day one of life and showed good response to treatment with diazoxide. The children were diagnosed with KS between the age of 10 months and 9 years. Typical clinical features of KS were seen in all patients but were of great variety, including dysmorphic facial features (n=5), cardiac anomalies (n=4), feeding difficulties with failure to thrive (n=4), and neurological symptoms such as afebrile seizures, muscle hypotonia and developmental delay (n=4).

Conclusion: In our study all children were diagnosed with hyperinsulinemic hypoglycemia in the first days of life, however, it took months to years to diagnose the KS. The predominance of female gender and KDM6A-related KS in our small cohort surprises, however, existing literature does not show similar findings. To facilitate the early identification of KS associated problems and to improve the treatment of affected patients with KS, KS should be considered in children with hyperinsulinemic hypoglycemia especially if there are other extrapancreatic/syndromic features.

Volume 92

58th Annual ESPE meeting

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.